Purdue Pharma will be sentenced on ​Tuesday in New Jersey federal court for deceiving government regulators and paying kickbacks to doctors to boost opioid ‌sales, completing a plea deal that clears the way for the company to dissolve in bankruptcy and use its assets to fund a $7.4 billion settlement intended to compensate people harmed by the opioid epidemic.